New Paragon spinout lands $275M financing — and reverse merger

The third spinout from Paragon Therapeutics launched on Wednesday with a new private financing — and, in an unusual move, a plan to go public within a few months.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *